Paul PARREN

Person

Utrecht, NL

People

Patents Grantslast 30 patents

Information Patent Grant
Polypeptide variants and uses thereof
- Patent number 12,173,076
- Issue date Dec 24, 2024
- GENMAB B.V.
- Frank Beurskens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antibodies for use in the treatment of hematological mal...
- Patent number 12,077,586
- Issue date Sep 3, 2024
- LAVA THERAPEUTICS N.V.
- Iris De Weerdt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multispecific antibodies against CD40 and CD137
- Patent number 12,077,596
- Issue date Sep 3, 2024
- GENMAB A/S
- Isil Altintas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody variants and uses thereof
- Patent number 12,049,512
- Issue date Jul 30, 2024
- GENMAB B.V.
- Paul Parren
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies
- Patent number 11,970,544
- Issue date Apr 30, 2024
- GENMAB A/S
- David Satijn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Multispecific antibodies against CD40 and CD137
- Patent number 11,939,388
- Issue date Mar 26, 2024
- GENMAB A/S
- Isil Altintas
- G01 - MEASURING TESTING
Information Patent Grant
Heterodimeric antibody Fc-containing proteins and methods for produ...
- Patent number 11,866,514
- Issue date Jan 9, 2024
- GENMAB A/S
- Aran Frank Labrijn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid molecules encoding binding agents to CD40 and 4-1BB (C...
- Patent number 11,814,411
- Issue date Nov 14, 2023
- BIONTECH SE
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulation of complement-dependent cytotoxicity through modificatio...
- Patent number 11,795,214
- Issue date Oct 24, 2023
- GENMAB A/S
- Paul Parren
- G01 - MEASURING TESTING
Information Patent Grant
Humanized or chimeric CD3 antibodies
- Patent number 11,613,575
- Issue date Mar 28, 2023
- GENMAB A/S
- Edward Norbert Van Den Brink
- G01 - MEASURING TESTING
Information Patent Grant
Bispecific antibodies against HER2 and CD3
- Patent number 11,578,141
- Issue date Feb 14, 2023
- GENMAB A/S
- Joost J. Neijssen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agent, uses and methods for treatment
- Patent number 11,548,950
- Issue date Jan 10, 2023
- H. Lundbeck A/S
- Lars Christian Biilmann Rønn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agents, uses and methods for the treatment of synucleinopathy
- Patent number 11,542,323
- Issue date Jan 3, 2023
- H. Lundbeck A/S
- Pekka Kallunki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agents, uses and methods for the treatment of synucleinopathy
- Patent number 11,524,995
- Issue date Dec 13, 2022
- H. Lundbeck A/S
- Pekka Kallunki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies an...
- Patent number 11,512,137
- Issue date Nov 29, 2022
- GENMAB HOLDING B.V.
- Simone Oostindie
- G01 - MEASURING TESTING
Information Patent Grant
Monoclonal antibodies against c-Met
- Patent number 11,512,140
- Issue date Nov 29, 2022
- GENMAB A/S
- Joost J. Neijssen
- G01 - MEASURING TESTING
Information Patent Grant
Production of heterodimeric proteins
- Patent number 11,492,371
- Issue date Nov 8, 2022
- GENMAB A/S
- Michael Gramer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inert format
- Patent number 11,485,796
- Issue date Nov 1, 2022
- GENMAB A/S
- Aran Frank Labrijn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Binding agents binding to PD-L1 and CD137 and use thereof
- Patent number 11,459,395
- Issue date Oct 4, 2022
- Genmab A/S
- Isil Altintas
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multispecific antibodies against CD40 and CD137
- Patent number 11,440,966
- Issue date Sep 13, 2022
- GENMAB A/S
- Isil Altintas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agents, uses and methods for the treatment of synucleinopathy
- Patent number 11,421,024
- Issue date Aug 23, 2022
- H. Lundbeck A/S
- Pekka Kallunki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies an...
- Patent number 11,396,553
- Issue date Jul 26, 2022
- GENMAB HOLDING B.V.
- Simone Oostindie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized or chimeric CD3 antibodies
- Patent number 11,359,015
- Issue date Jun 14, 2022
- Genmab A/S
- Rik Rademaker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating cancer with human monoclonal antibodies against...
- Patent number 11,339,215
- Issue date May 24, 2022
- CORMORANT PHARMACEUTICALS AB
- Jessica Teeling
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies against human CD38
- Patent number 11,230,604
- Issue date Jan 25, 2022
- GENMAB A/S
- Michel De Weers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dimeric protein with triple mutations
- Patent number 11,180,572
- Issue date Nov 23, 2021
- GENMAB B.V.
- Rob N. De Jong
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies
- Patent number 11,130,819
- Issue date Sep 28, 2021
- GENMAB A/S
- David Satijn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of producing multispecific antibodies against CD40 and CD137
- Patent number 11,091,557
- Issue date Aug 17, 2021
- GENMAB A/S
- Isil Altintas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies against HER2
- Patent number 11,091,553
- Issue date Aug 17, 2021
- GENMAB A/S
- Bart De Goeij
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multispecific antibodies against CD40 and CD137
- Patent number 11,084,882
- Issue date Aug 10, 2021
- Genmab A/S
- Isil Altintas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODY VARIANTS AND USES THEREOF
- Publication number 20250043018
- Publication date Feb 6, 2025
- Paul PARREN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD33 x Vd2 MULTISPECIFIC ANTIBODIES FOR THE TREATMENT OF CANCER
- Publication number 20240409634
- Publication date Dec 12, 2024
- JANSSEN BIOTECH, INC.
- Patrick John DOONAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES
- Publication number 20240392032
- Publication date Nov 28, 2024
- GENMAB A/S
- David SATIJN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES THAT BIND PSMA AND GAMMA-DELTA T CELL RECEPTORS
- Publication number 20240317888
- Publication date Sep 26, 2024
- LAVA THERAPEUTICS N.V.
- Robertus Cornelis Roovers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST PD-L1
- Publication number 20240317861
- Publication date Sep 26, 2024
- GENMAB A/S
- Isil ALTINTAS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR
- Publication number 20240294661
- Publication date Sep 5, 2024
- GENMAB A/S
- David SATIJN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING BISPECIFIC ANTI-CD37 ANTIBODIES
- Publication number 20240252635
- Publication date Aug 1, 2024
- Simone OOSTINDIE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGONISTIC TNF RECEPTOR BINDING AGENTS
- Publication number 20240254249
- Publication date Aug 1, 2024
- BIONTECH SE
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA
- Publication number 20240228662
- Publication date Jul 11, 2024
- GENMAB A/S
- Michel DE WEERS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HETERODIMERIC ANTIBODY FC-CONTAINING PROTEINS AND METHODS FOR PRODU...
- Publication number 20240209117
- Publication date Jun 27, 2024
- GENMAB A/S
- Aran Frank LABRIJN
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS
- Publication number 20240165226
- Publication date May 23, 2024
- GENMAB A/S
- Jan Van De Winkel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES THAT BIND CD123 AND GAMMA-DELTA T CELL RECEPTORS
- Publication number 20240141071
- Publication date May 2, 2024
- LAVA THERAPEUTICS N.V.
- Robertus Cornelis ROOVERS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA
- Publication number 20240132620
- Publication date Apr 25, 2024
- GENMAB A/S
- Michel DE WEERS
- G01 - MEASURING TESTING
Information Patent Application
BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AN...
- Publication number 20240117064
- Publication date Apr 11, 2024
- GENMAB HOLDING B.V.
- Simone OOSTINDIE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES BINDING AXL
- Publication number 20240091352
- Publication date Mar 21, 2024
- GENMAB A/S
- Esther BREIJ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST C-MET
- Publication number 20240084036
- Publication date Mar 14, 2024
- GENMAB A/S
- Joost J. Neijssen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AN...
- Publication number 20240076397
- Publication date Mar 7, 2024
- GENMAB HOLDING B.V.
- Simone OOSTINDIE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMAN ANTIBODIES AGAINST TISSUE FACTOR AND METHODS OF USE THEREOF
- Publication number 20230416403
- Publication date Dec 28, 2023
- GENMAB A/S
- Sandra VERPLOEGEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AN...
- Publication number 20230399414
- Publication date Dec 14, 2023
- GENMAB HOLDING B.V,
- Simone OOSTINDIE
- G01 - MEASURING TESTING
Information Patent Application
HUMANIZED OR CHIMERIC CD3 ANTIBODIES
- Publication number 20230374131
- Publication date Nov 23, 2023
- GENMAB A/S
- Edward Norbert VAN DEN BRINK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INERT FORMAT
- Publication number 20230322947
- Publication date Oct 12, 2023
- GENMAB A/S
- Aran Frank LABRIJN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT
- Publication number 20230321261
- Publication date Oct 12, 2023
- GENMAB A/S
- Julia BOSHUIZEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Agents, Uses and Methods for the Treatment of Synucleinopathy
- Publication number 20230312693
- Publication date Oct 5, 2023
- H. LUNDBECK A/S
- Pekka KALLUNKI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES THAT BIND GAMMA-DELTA T CELL RECEPTORS
- Publication number 20230303694
- Publication date Sep 28, 2023
- LAVA THERAPEUTICS N.V.
- Paul Willem Henri Ida PARREN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES THAT BIND PSMA AND GAMMA-DELTA T CELL RECEPTORS
- Publication number 20230272110
- Publication date Aug 31, 2023
- LAVA THERAPEUTICS N.V.
- Robertus Cornelis Roovers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODIES BINDING TO 5T4 AND CD3 FOR USE IN TREATMENT O...
- Publication number 20230257479
- Publication date Aug 17, 2023
- GENMAB A/S
- David SATIJN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PRODUCTION OF HETERODIMERIC PROTEINS
- Publication number 20230227495
- Publication date Jul 20, 2023
- GENMAB A/S
- Michael GRAMER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGENT, USES AND METHODS FOR TREATMENT
- Publication number 20230159643
- Publication date May 25, 2023
- H. LUNDBECK A/S
- Lars Christian Biilmann Rønn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYPEPTIDE VARIANTS AND USES THEREOF
- Publication number 20230107363
- Publication date Apr 6, 2023
- GENMAB B.V.
- Rob DE JONG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOF
- Publication number 20230087745
- Publication date Mar 23, 2023
- GENMAB A/S
- Isil ALTINTAS
- C07 - ORGANIC CHEMISTRY

Paul PARREN

Person

Patents Grantslast 30 patents

Polypeptide variants and uses thereof

Bispecific antibodies for use in the treatment of hematological mal...

Multispecific antibodies against CD40 and CD137

Antibody variants and uses thereof

Antibodies

Multispecific antibodies against CD40 and CD137

Heterodimeric antibody Fc-containing proteins and methods for produ...

Nucleic acid molecules encoding binding agents to CD40 and 4-1BB (C...

Modulation of complement-dependent cytotoxicity through modificatio...

Humanized or chimeric CD3 antibodies

Bispecific antibodies against HER2 and CD3

Agent, uses and methods for treatment

Agents, uses and methods for the treatment of synucleinopathy

Agents, uses and methods for the treatment of synucleinopathy

Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies an...

Monoclonal antibodies against c-Met

Production of heterodimeric proteins

Inert format

Binding agents binding to PD-L1 and CD137 and use thereof

Multispecific antibodies against CD40 and CD137

Agents, uses and methods for the treatment of synucleinopathy

Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies an...

Humanized or chimeric CD3 antibodies

Methods of treating cancer with human monoclonal antibodies against...

Antibodies against human CD38

Dimeric protein with triple mutations

Antibodies

Methods of producing multispecific antibodies against CD40 and CD137

Monoclonal antibodies against HER2

Multispecific antibodies against CD40 and CD137

Patents Applicationslast 30 patents

ANTIBODY VARIANTS AND USES THEREOF

CD33 x Vd2 MULTISPECIFIC ANTIBODIES FOR THE TREATMENT OF CANCER

ANTIBODIES

ANTIBODIES THAT BIND PSMA AND GAMMA-DELTA T CELL RECEPTORS

ANTIBODIES AGAINST PD-L1

HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR

PHARMACEUTICAL COMPOSITIONS COMPRISING BISPECIFIC ANTI-CD37 ANTIBODIES

AGONISTIC TNF RECEPTOR BINDING AGENTS

ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA

HETERODIMERIC ANTIBODY FC-CONTAINING PROTEINS AND METHODS FOR PRODU...

COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS

ANTIBODIES THAT BIND CD123 AND GAMMA-DELTA T CELL RECEPTORS

ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA

BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AN...

ANTIBODIES BINDING AXL

MONOCLONAL ANTIBODIES AGAINST C-MET

BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AN...

HUMAN ANTIBODIES AGAINST TISSUE FACTOR AND METHODS OF USE THEREOF

BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AN...

HUMANIZED OR CHIMERIC CD3 ANTIBODIES

INERT FORMAT

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT

Agents, Uses and Methods for the Treatment of Synucleinopathy

ANTIBODIES THAT BIND GAMMA-DELTA T CELL RECEPTORS

ANTIBODIES THAT BIND PSMA AND GAMMA-DELTA T CELL RECEPTORS

BISPECIFIC ANTIBODIES BINDING TO 5T4 AND CD3 FOR USE IN TREATMENT O...

PRODUCTION OF HETERODIMERIC PROTEINS

AGENT, USES AND METHODS FOR TREATMENT

POLYPEPTIDE VARIANTS AND USES THEREOF

BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOF